NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-104-1996-2-EP-04 BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE EP National Stage 97926586.5 Abandoned
NCI E-104-1996-1-US-01 BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE US CIP 08/857,636 6552181 Abandoned PDF
NCI E-104-1996-2-AU-02 BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE AU National Stage 31314/97 Abandoned
NCI E-104-1996-2-PCT-01 A BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE PCT PCT COMB PCT/US1997/008433 Expired
NCI E-104-1996-2-JP-05 BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE JP National Stage 1997-541164 Abandoned
NCI E-104-1996-2-CA-03 BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE CA National Stage 2266408 Abandoned
NCI E-105-1996-1-US-01 CHIMERIC GAG PSEUDOVIRIONS US CIP 08/857,385 6099847 Abandoned PDF
NCI E-038-1996-0-PCT-02 METHODS FOR SEQUENCING LARGE NUCLEIC ACID SEGMENTS AND COMPOSITIONS FOR LARGE SEQUENCING PROJECTS PCT PCT PCT/US1997/008114 Expired
NIAID E-123-1992-3-BR-07 ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE COMPOSITIONS BR DIV PI1100530-0 Abandoned
NIDDK E-138-1992-1-NZ-14 A METHOD OF IDENTIFYING CFTR-BINDING COMPOUNDS USEFUL FOR ACTIVATING CHLORIDE CONDUCTANCE IN ANIMAL CELLS NZ National Stage 296765 Abandoned
NCI E-046-1991-1-AU-19 METHOD OF PREVENTING TUMOR METASTASIS AU DIV 20812/97 Abandoned
NCI E-037-1994-0-US-03 ETS1-GENE: A HUMAN TUMOR SUPPRESSOR GENE US DIV 08/854,522 5795866 Abandoned PDF
NIAID E-142-1996-1-US-01 PRODUCTION OF INFECTIOUS RESPIRATORY SYNCYTIAL VIRUS FROM CLONED NUCLEOTIDE SEQUENCES US 60/046,141 Abandoned
NIDDK E-006-1998-0-US-01 METHODS AND COMPOSITIONS FOR REDUCING ISCHEMIC INJURY OF THE HEART BY ADMINISTRATING ADENOSINE A3 AND ADENOSINE A1 RECEPTOR AGONISTS US 60/046,030 Abandoned
NCI E-186-1995-0-AU-04 MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE AU National Stage 28290/97 Expired
NCI E-234-1992-3-US-01 ASSAYS FOR IDENTIFYING ANTIOXIDANT COMPOUNDS WHICH PROTECT AGAINST FREE RADICAL-INDUCED DNA LESIONS US CIP 08/852,355 6017706 Abandoned PDF
NCI E-186-1995-0-PCT-03 MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE PCT PCT PCT/US1997/007625 Expired
NCI E-186-1995-0-JP-05 MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE JP National Stage 1997-540143 Abandoned
NCI E-186-1995-0-EP-06 MUTANT AEQUOREA VICTORIA FLUORESCENT PROTEINS HAVING INCREASED CELLULAR FLUORESCENCE EP National Stage 97922686.7 Abandoned
NCI E-093-1996-1-US-01 O2-ARYL SUBSTITUTED DIAZENIUMDIOLATES AND USES THEREOF US 60/045,917 Abandoned
NIEHS E-056-1998-1-US-04 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US DIV 08/850,727 6162897 Expired PDF
NCI E-071-1992-1-US-02 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF MRNA US CON 08/850,049 5965726 Expired PDF
NIEHS E-056-1998-1-US-02 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US DIV 08/850,062 Abandoned
NIEHS E-056-1998-0-US-01 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US CIP 08/850,085 Expired
NIEHS E-056-1998-1-US-03 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US FWC 08/850,142 Abandoned
NIEHS E-056-1998-1-US-01 17Q LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILTY GENE US CON 08/848,962 Abandoned
NCI E-157-1997-0-US-01 IMMUNOTOXINS DIRECTED AGAINST MALIGNANT B CELLS US 60/046,895 Abandoned
NIDDK E-058-2000-0-US-01 Mass Spectrometry of Colonization Factors US 60/045,511 Abandoned
NIAID E-146-1997-0-US-01 Pvs28, A VACCINE CANDIDATE FOR BLOCKING TRANSMISSION OF PLASMODIUM VIVAX US 60/045,283 Abandoned
NICHD E-016-1996-0-CA-04 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS CA National Stage 2253673 Expired
NICHD E-016-1996-0-JP-07 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS JP National Stage 1997-539232 Expired
NICHD E-016-1996-0-MX-08 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS MX National Stage 989124 Expired
NICHD E-016-1996-0-ES-18 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS ES EP 97923523.1 Expired
NICHD E-016-1996-0-NL-19 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS NL EP 97923523.1 Expired
NICHD E-016-1996-0-PT-23 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS PT EP 97923523.1 Expired
NICHD E-016-1996-0-AT-16 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS AT EP 97923523.1 Expired
NICHD E-016-1996-0-BE-13 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS BE EP 97923523.1 Expired
NICHD E-016-1996-0-CH-17 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS CH EP 97923523.1 Expired
NICHD E-016-1996-0-SE-20 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS SE EP 97923523.1 Expired
NICHD E-016-1996-0-GB-11 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS GB EP 97923523.1 Expired
NICHD E-016-1996-0-GR-15 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS GR EP 3034562 Expired
NICHD E-016-1996-0-IE-22 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS IE EP 97923523.1 Expired
NICHD E-016-1996-0-IT-12 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS IT EP 97923523.1 Expired
NICHD E-016-1996-0-DK-14 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS DK EP 97923523.1 Expired
NICHD E-016-1996-0-FI-21 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS FI EP 97923523.1 Expired
NICHD E-016-1996-0-DE-09 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS DE EP 97923523.1 Expired
NICHD E-016-1996-0-FR-10 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS FR EP 97923523.1 Expired
NICHD E-016-1996-0-EP-05 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS EP National Stage 97923523.1 Expired
NICHD E-016-1996-0-AU-03 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS AU National Stage 29304/97 Expired
NICHD E-016-1996-0-PCT-02 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS PCT PCT PCT/US1997/007373 Expired